Surgery, Gastroenterology and Oncology
Vol. 25, Nr. 3, June 2020
Factors Impacting Survival Outcomes after Curative Resection for Primary Duodenal Adenocarcinoma
Masayuki Urabe, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, Shusuke Haruta, Masaki Ueno, Masaji Hashimoto
ORIGINAL PAPER, June 2020
Article DOI: 10.21614/sgo-25-3-132
Background: Primary duodenal adenocarcinoma (PDA) is a rare gastrointestinal tumor and factors predicting survival outcomes after curative resection have yet to be fully elucidated.

Methods: Applying the Cox proportional hazard model, we retrospectively evaluated associations between overall relapse-free survivals (OS RFS) and 18 clinicopathological factors in 33 patients who had undergone R0 resection for PDA.

Results: Univariate analysis revealed worsening RFS to be significantly related to pancreatic invasion, multiple nodal metastases, and the preoperative serum carcinoembryonic antigen level. Pancreatic invasion and multiple nodal metastases were also found to be significantly associated with poorer OS in the univariate analysis. In multivariate analysis, only pancreatic invasion was an independent predictor of OS (hazard ratio [HR] 5.27, 95% confidence interval [CI] 1.15-24.2, P = 0.033). As to RFS, both pancreatic invasion and multiple nodal metastases correlated independently with unfavorable outcomes (HR 42.8, 95% CI 3.59 - 510, P = 0.003; HR 216, 95% CI 6.86 - 6.8 x 103, P = 0.002; respectively).
Only one of the 19 patients with PDA limited to the mucosal submucosal layer developed recurrent disease (local site), while seven patients with pancreatic invasion and or multiple nodal metastases all experienced meta chronous distant recurrence.

Conclusion: While the likelihood of progression to systemic disease after meticulous surgical removal is very low in early-stage PDA, patients with PDA invading the pancreas and or metastasizing to multiple lymph nodes are at high risk of developing distant relapse and may benefit from additional systemic therapy.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 317



Video Abstracts


Open Access Fee

Members of the IASGO will not pay open access fee. Non-members of IASGO will pay publishing fee of €150. Publishing fee, which will cover the DOI, plagiarism check, the editing work.


Journal Subscriptions

Current Issue

June 2020

Supplements

Instructions for authors
Online submission
Contact
Print ISSN: 2559 - 723X

ISSN-L: 2559 - 723X

ISSN online: 2601 - 1700

Surgery, Gastroenterology and Oncology is indexed in Scopus, CrossRef (DOI: 10.21614/sgo)



Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.